👪

Inheritance

2

Autosomal dominant HP:0000006

Autosomal dominant inheritance

Show evidence (1 reference)

PMID:25145518 SUPPORT Human Clinical

"Segregation analysis suggested autosomal-dominant inheritance of the combined phenotype."

A familial sinus node dysfunction and noncompaction pedigree showed autosomal-dominant segregation with HCN4-related disease.

Autosomal recessive HP:0000007

Autosomal recessive inheritance

Show evidence (1 reference)

PMID:14523039 SUPPORT Human Clinical

"Our findings reveal a molecular basis for some forms of congenital SSS and define a recessive disorder of a human heart voltage-gated sodium channel."

Compound heterozygous SCN5A disease establishes a recessive congenital branch within familial sick sinus syndrome.

⚙

Pathophysiology

5

Heritable Sinoatrial Node Pacemaker Dysfunction

Germline variation can disturb sinoatrial node pacemaker-cell impulse generation, cardiac conduction, and heart-rate adaptation to physiologic demand.

cardiac pacemaker cell of sinoatrial node link

SA node cell action potential link ↓ DECREASED cardiac conduction link ↓ DECREASED

sinoatrial node link

Downstream

Bradyarrhythmia and Hypoperfusion Impaired pacemaker function or conduction slows atrial activation and can produce pauses, bradycardia, and low-output symptoms.

Show evidence (2 references)

PMID:37194974 SUPPORT Other

"The sinoatrial node (SAN) is the primary pacemaker of the mammalian heart, initiating its electrical activation and ensuring that the heart's functional cardiac output meets physiological demand."

This establishes the affected tissue and the normal pacemaker function disrupted in familial sick sinus syndrome.

PMID:37194974 SUPPORT Other

"SND has a complex aetiology, with both pre-existing disease and heritable genetic variation predisposing individuals to this pathology."

This review directly supports heritable genetic variation as a cause of sinoatrial node dysfunction.

HCN4 Pacemaker Current Loss of Function

HCN4 variants impair the hyperpolarization-activated pacemaker current in sinoatrial node cells. Dominant-negative or gating-shift effects reduce pacemaker current availability and slow diastolic depolarization, producing bradycardia and sinus node dysfunction.

cardiac pacemaker cell of sinoatrial node link

regulation of monoatomic ion transmembrane transport link ↓ DECREASED

monoatomic ion channel activity link ⚠ ABNORMAL

sinoatrial node link

Downstream

Bradyarrhythmia and Hypoperfusion Reduced pacemaker current slows sinoatrial node firing and can produce sinus bradycardia, pauses, and hypoperfusion symptoms.

Show evidence (3 references)

PMID:25145517 SUPPORT Human Clinical

"One of these, p.Gly482Arg in HCN4, segregated with the combined bradycardia and LVNC phenotype in the entire family."

The family study supports HCN4 as a segregating familial bradycardia gene.

PMID:25145517 SUPPORT In Vitro

"In electrophysiological studies, all found HCN4 mutations showed a more negative voltage dependence of activation, consistent with the observed bradycardia."

Functional electrophysiology links HCN4 variants to reduced pacemaker current behavior consistent with bradycardia.

PMID:25145518 SUPPORT In Vitro

"Mutant subunits were nonfunctional and exerted dominant-negative effects on wild-type current."

This supports a dominant-negative HCN4 loss-of-function mechanism for familial sinus node dysfunction.

SCN5A Sodium Current Loss of Function

SCN5A variants reduce Nav1.5 sodium current through gating, trafficking, or temperature-sensitive loss-of-function mechanisms, lowering myocardial excitability and impairing cardiac conduction in familial or congenital sick sinus syndrome.

cardiac muscle cell link cardiac pacemaker cell of sinoatrial node link

cardiac conduction link ↓ DECREASED cardiac muscle cell action potential involved in contraction link ↓ DECREASED

monoatomic ion channel activity link ⚠ ABNORMAL

heart link

Downstream

Bradyarrhythmia and Hypoperfusion Sodium-current loss of function can impair impulse initiation or propagation, leading to bradyarrhythmia and symptomatic pauses.

Show evidence (3 references)

PMID:14523039 SUPPORT Human Clinical

"Probands from three kindreds exhibited compound heterozygosity for six distinct SCN5A alleles, including two mutations previously associated with dominant disorders of cardiac excitability."

This identifies compound heterozygous SCN5A alleles in pediatric congenital sick sinus syndrome kindreds.

PMID:14523039 SUPPORT In Vitro

"Biophysical characterization of the mutants using heterologously expressed recombinant human heart sodium channels demonstrate loss of function or significant impairments in channel gating (inactivation) that predict reduced myocardial excitability."

Functional channel assays directly support reduced sodium-channel excitability as a mechanism.

PMID:34348284 SUPPORT In Vitro

"At body temperature, Nav1.5-G1712S additionally exhibited an enhanced slow inactivation and an impaired recovery from inactivation."

This provides variant-level evidence for temperature-sensitive Nav1.5 gating defects in a family with sick sinus syndrome and conduction disease.

Bradyarrhythmia and Hypoperfusion

Reduced sinoatrial node firing or conduction produces sinus bradycardia, sinus arrest, sinoatrial exit block, chronotropic incompetence, and alternating bradycardia-tachycardia syndrome; symptoms arise when pauses or slow rates reduce cerebral or systemic perfusion.

cardiac conduction link ↓ DECREASED

Downstream

Syncope and Sudden Cardiac Death Severe bradycardia, sinus pauses, or asystole reduce cerebral perfusion, producing syncope and the risk of asystolic sudden death.

Show evidence (2 references)

PMID:37194974 SUPPORT Other

"SAN dysfunction (SND) can cause complex cardiac arrhythmias that can manifest as severe sinus bradycardia, sinus arrest, chronotropic incompetence and increased susceptibility to atrial fibrillation, among other cardiac conditions."

This review links sinoatrial node dysfunction to the major rhythm manifestations curated for familial sick sinus syndrome.

PMID:34383451 SUPPORT Human Clinical

"Clinical symptoms result from the hypoperfusion of end organs."

This supports hypoperfusion as the downstream symptom mechanism of clinically significant bradyarrhythmia.

Syncope and Sudden Cardiac Death

Loss of effective cardiac output from severe bradyarrhythmia, prolonged sinus pauses, or asystole causes transient cerebral hypoperfusion (syncope and presyncope) and, when a pause does not terminate, carries a risk of asystolic sudden cardiac death. In familial sick sinus syndrome these bradyarrhythmic events are the shared clinical endpoint, and in pedigrees with cardiomyopathy overlap (for example LMNA disease) sudden death is part of the familial phenotype.

Show evidence (2 references)

PMID:34383451 SUPPORT Human Clinical

"About 50% of patients present with cerebral hypoperfusion (e.g., syncope, presyncope, lightheadedness, cerebrovascular accident)."

Supports syncope and presyncope as the cerebral-hypoperfusion endpoint of bradyarrhythmia in sinus node dysfunction.

PMID:27182706 SUPPORT Human Clinical

"The proband is a 63-year-old male with a family history of individuals (>10) with sinus node dysfunction, ventricular arrhythmia, cardiomyopathy, heart failure, and sudden death."

A multigenerational familial sick sinus syndrome pedigree documents sudden death as part of the inherited phenotype, supporting it as the terminal outcome of the cascade.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

8

Cardiovascular 4

Bradycardia Bradycardia (HP:0001662)

Show evidence (1 reference)

PMID:34383451 SUPPORT Human Clinical

"Electrocardiography findings include sinus bradycardia, sinus pauses or arrest, sinoatrial exit block, chronotropic incompetence, or alternating bradycardia and tachycardia (i.e., bradycardia-tachycardia syndrome)."

Bradycardia is listed as a core ECG manifestation of sinus node dysfunction.

Syncope or Presyncope Syncope (HP:0001279)

Show evidence (1 reference)

PMID:34383451 SUPPORT Human Clinical

"About 50% of patients present with cerebral hypoperfusion (e.g., syncope, presyncope, lightheadedness, cerebrovascular accident)."

Syncope and presyncope are direct manifestations of cerebral hypoperfusion in sinus node dysfunction.

Palpitations Palpitations (HP:0001962)

Show evidence (1 reference)

PMID:34383451 SUPPORT Human Clinical

"Other symptoms include palpitations, decreased physical activity tolerance, angina, muscular fatigue, or oliguria."

Palpitations are listed among symptomatic presentations of sinus node dysfunction.

Atrial Fibrillation Atrial fibrillation (HP:0005110)

Show evidence (1 reference)

PMID:37194974 SUPPORT Other

"SAN dysfunction (SND) can cause complex cardiac arrhythmias that can manifest as severe sinus bradycardia, sinus arrest, chronotropic incompetence and increased susceptibility to atrial fibrillation, among other cardiac conditions."

Familial sick sinus syndrome can include increased atrial fibrillation susceptibility as part of the sinoatrial-node dysfunction spectrum.

Constitutional 2

Chronotropic Incompetence Exercise intolerance (HP:0003546)

Show evidence (1 reference)

PMID:34383451 SUPPORT Human Clinical

"The patient's inability to reach a heart rate of at least 80% of their predicted maximum (220 beats per minute - age) may indicate chronotropic incompetence, which is present in 50% of patients with sinus node dysfunction."

Chronotropic incompetence is explicitly described as a common functional consequence of sinus node dysfunction; the available HPO term captures the exercise-intolerance manifestation.

Fatigue Fatigue (HP:0012378)

Show evidence (1 reference)

PMID:34383451 SUPPORT Human Clinical

"Other symptoms include palpitations, decreased physical activity tolerance, angina, muscular fatigue, or oliguria."

Muscular fatigue is listed among symptoms of sinus node dysfunction.

Other 2

Sinus Pauses or Sinoatrial Exit Block Abnormal electrophysiology of sinoatrial node origin (HP:0011702)

Show evidence (1 reference)

PMID:34383451 SUPPORT Human Clinical

"Electrocardiography findings include sinus bradycardia, sinus pauses or arrest, sinoatrial exit block, chronotropic incompetence, or alternating bradycardia and tachycardia (i.e., bradycardia-tachycardia syndrome)."

The review explicitly lists sinus pauses or arrest and sinoatrial exit block as ECG manifestations.

Left ventricular noncompaction Left ventricular noncompaction (HP:0030682)

Show evidence (1 reference)

PMID:25145517 SUPPORT Human Clinical

"Subsequent screening of HCN4 in 3 additional families with the same clinical combination of bradycardia and LVNC identified HCN4 mutations in each."

HCN4-related familial sick sinus syndrome is reported with left ventricular noncompaction in multiple families.

🧬

Genetic Associations

6

HCN4 loss-of-function variants (Causative)

Show evidence (2 references)

PMID:25145517 SUPPORT Human Clinical

"Familial forms of primary sinus bradycardia have sometimes been attributed to mutations in HCN4, SCN5A, and ANK2."

This review of familial bradycardia pedigrees identifies HCN4 as one of the established familial sinus-bradycardia genes.

PMID:25145517 SUPPORT Human Clinical

"Subsequent screening of HCN4 in 3 additional families with the same clinical combination of bradycardia and LVNC identified HCN4 mutations in each."

Multiple families with the combined bradycardia phenotype had HCN4 mutations.

SCN5A loss-of-function variants (Causative)

Show evidence (2 references)

PMID:14523039 SUPPORT Human Clinical

"Based on prior associations with disorders of cardiac rhythm and conduction, we screened the alpha subunit of the cardiac sodium channel (SCN5A) as a candidate gene in ten pediatric patients from seven families who were diagnosed with congenital SSS during the first decade of life."

This supports SCN5A as a candidate and confirmed disease gene in pediatric congenital sick sinus syndrome kindreds.

PMID:34348284 SUPPORT Human Clinical

"We conclude that G1712S is a pathogenic SCN5A loss-of function mutation at physiological temperature associated with an overlapping presentation of BrS, SSS, and cardiac conduction disease."

This family report supports SCN5A loss-of-function as a contributor to symptomatic sick sinus syndrome and conduction disease.

ANK2-associated susceptibility (Causative)

Show evidence (1 reference)

PMID:25145517 SUPPORT Human Clinical

"Familial forms of primary sinus bradycardia have sometimes been attributed to mutations in HCN4, SCN5A, and ANK2."

The HCN4 family paper names ANK2 alongside HCN4 and SCN5A as a familial primary sinus bradycardia gene.

LMNA splice-site variants (Causative)

Show evidence (2 references)

PMID:27182706 SUPPORT Human Clinical

"The proband is a 63-year-old male with a family history of individuals (>10) with sinus node dysfunction, ventricular arrhythmia, cardiomyopathy, heart failure, and sudden death."

This describes a multigenerational familial sick sinus syndrome pedigree with cardiomyopathy and sudden-death overlap.

PMID:27182706 SUPPORT Human Clinical

"The results identified LMNA c.357-2A>G, a novel heterozygous splice-site mutation as the primary mutation with rare or novel variants in HCN4, MYBPC3, PKP4, TMPO, TTN, DMPK and KCNJ10 as potential modifiers and a mechanism consistent with haploinsufficiency."

Exome sequencing identified an LMNA splice-site mutation as the primary familial variant with additional possible modifiers.

KRT8 p.Gly62Cys susceptibility variant (Risk Factor)

Show evidence (1 reference)

PMID:33580673 SUPPORT Human Clinical

"We report the associations of variants at six loci with SSS, including a missense variant in KRT8 that confers high risk in homozygotes and points to a mechanism specific to SSS development."

The GWAS/meta-analysis supports KRT8 as a sick sinus syndrome risk locus rather than a classic Mendelian familial gene.

MYH6-associated susceptibility (Risk Factor)

Show evidence (1 reference)

PMID:33580673 SUPPORT Human Clinical

"Variants at six loci associated with SSS, a reported missense variant in MYH6, known atrial fibrillation (AF)/electrocardiogram variants at PITX2, ZFHX3, TTN/CCDC141, and SCN10A and a low-frequency (MAF = 1.1-1.8%) missense variant, p.Gly62Cys in KRT8 encoding the intermediate filament protein keratin 8."

This supports MYH6 as part of the broader sick sinus syndrome genetic risk architecture.

💊

Treatments

1

Permanent Pacemaker Implantation

Action: pacemaker implantation MAXO:0009034

Permanent pacemaker therapy is the main established treatment for confirmed, symptomatic sinus node dysfunction with clinically significant bradycardia or pauses; current therapy does not correct the underlying genetic mechanism.

Show evidence (2 references)

PMID:34383451 SUPPORT Human Clinical

"First-line treatment for patients with confirmed sinus node dysfunction is permanent pacemaker placement with atrial-based pacing and limited ventricular pacing when necessary."

This supports pacemaker implantation as first-line treatment for confirmed symptomatic sinus node dysfunction.

PMID:38667717 SUPPORT Human Clinical

"In sinus node dysfunction, symptomatic bradycardia is the most relevant recommendation for pacing."

Pediatric CIED guideline review supports symptom-correlated bradycardia as the key pacing indication.

🌍

Environmental Factors

1

Reversible extrinsic contributors to sinus node dysfunction

Familial sick sinus syndrome is primarily genetic, but medications, metabolic abnormalities, and other extrinsic contributors should be excluded or corrected because they can mimic or worsen sinoatrial node dysfunction.

Show evidence (1 reference)

PMID:34383451 SUPPORT Human Clinical

"The causes of sinus node dysfunction are intrinsic (e.g., degenerative idiopathic fibrosis, cardiac remodeling) or extrinsic (e.g., medications, metabolic abnormalities) to the sinoatrial node."

This supports reversible extrinsic contributors as differential or modifying factors rather than the primary familial cause.

{ }

Source YAML

click to show

name: Familial Sick Sinus Syndrome
creation_date: "2026-05-09T12:44:06Z"
updated_date: "2026-05-09T22:34:54Z"
category: Genetic
description: >-
  Familial sick sinus syndrome is an inherited sinoatrial-node dysfunction
  disorder in which germline variation in cardiac pacemaker, ion-channel,
  conduction, or structural myocardial genes impairs impulse generation or
  propagation. The clinical spectrum includes sinus bradycardia, sinus arrest or
  pauses, sinoatrial exit block, chronotropic incompetence, atrial fibrillation
  susceptibility, and hypoperfusion symptoms such as syncope.
disease_term:
  preferred_term: familial sick sinus syndrome
  term:
    id: MONDO:0012061
    label: familial sick sinus syndrome
parents:
- Sick Sinus Syndrome
- Cardiogenetic Rhythm Disorder
synonyms:
- Familial sinus node dysfunction
- Hereditary sick sinus syndrome
- Familial sinoatrial node dysfunction
- SSS1
inheritance:
- name: Autosomal dominant
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  evidence:
  - reference: PMID:25145518
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Segregation analysis suggested autosomal-dominant inheritance of the
      combined phenotype.
    explanation: >-
      A familial sinus node dysfunction and noncompaction pedigree showed
      autosomal-dominant segregation with HCN4-related disease.
- name: Autosomal recessive
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  evidence:
  - reference: PMID:14523039
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Our findings reveal a molecular basis for some forms of congenital SSS
      and define a recessive disorder of a human heart voltage-gated sodium
      channel.
    explanation: >-
      Compound heterozygous SCN5A disease establishes a recessive congenital
      branch within familial sick sinus syndrome.
pathophysiology:
- name: Heritable Sinoatrial Node Pacemaker Dysfunction
  conforms_to: "cardiac_ion_channel_repolarization#Sinoatrial Node Pacemaker Dysfunction"
  role: effector
  description: >-
    Germline variation can disturb sinoatrial node pacemaker-cell impulse
    generation, cardiac conduction, and heart-rate adaptation to physiologic
    demand.
  cell_types:
  - preferred_term: cardiac pacemaker cell of sinoatrial node
    term:
      id: CL:1000477
      label: cardiac pacemaker cell of sinoatrial node
  biological_processes:
  - preferred_term: SA node cell action potential
    term:
      id: GO:0086015
      label: SA node cell action potential
    modifier: DECREASED
  - preferred_term: cardiac conduction
    term:
      id: GO:0061337
      label: cardiac conduction
    modifier: DECREASED
  locations:
  - preferred_term: sinoatrial node
    term:
      id: UBERON:0002351
      label: sinoatrial node
  evidence:
  - reference: PMID:37194974
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The sinoatrial node (SAN) is the primary pacemaker of the mammalian heart,
      initiating its electrical activation and ensuring that the heart's
      functional cardiac output meets physiological demand.
    explanation: >-
      This establishes the affected tissue and the normal pacemaker function
      disrupted in familial sick sinus syndrome.
  - reference: PMID:37194974
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      SND has a complex aetiology, with both pre-existing disease and heritable
      genetic variation predisposing individuals to this pathology.
    explanation: >-
      This review directly supports heritable genetic variation as a cause of
      sinoatrial node dysfunction.
  downstream:
  - target: Bradyarrhythmia and Hypoperfusion
    description: >-
      Impaired pacemaker function or conduction slows atrial activation and can
      produce pauses, bradycardia, and low-output symptoms.
- name: HCN4 Pacemaker Current Loss of Function
  conforms_to: "cardiac_ion_channel_repolarization#Cardiac Ion-Channel or Calcium-Handling Variant"
  role: trigger
  description: >-
    HCN4 variants impair the hyperpolarization-activated pacemaker current in
    sinoatrial node cells. Dominant-negative or gating-shift effects reduce
    pacemaker current availability and slow diastolic depolarization, producing
    bradycardia and sinus node dysfunction.
  cell_types:
  - preferred_term: cardiac pacemaker cell of sinoatrial node
    term:
      id: CL:1000477
      label: cardiac pacemaker cell of sinoatrial node
  molecular_functions:
  - preferred_term: monoatomic ion channel activity
    term:
      id: GO:0005216
      label: monoatomic ion channel activity
    modifier: ABNORMAL
  biological_processes:
  - preferred_term: regulation of monoatomic ion transmembrane transport
    term:
      id: GO:0034765
      label: regulation of monoatomic ion transmembrane transport
    modifier: DECREASED
  locations:
  - preferred_term: sinoatrial node
    term:
      id: UBERON:0002351
      label: sinoatrial node
  evidence:
  - reference: PMID:25145517
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      One of these, p.Gly482Arg in HCN4, segregated with the combined
      bradycardia and LVNC phenotype in the entire family.
    explanation: >-
      The family study supports HCN4 as a segregating familial bradycardia gene.
  - reference: PMID:25145517
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      In electrophysiological studies, all found HCN4 mutations showed a more
      negative voltage dependence of activation, consistent with the observed
      bradycardia.
    explanation: >-
      Functional electrophysiology links HCN4 variants to reduced pacemaker
      current behavior consistent with bradycardia.
  - reference: PMID:25145518
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Mutant subunits were nonfunctional and exerted dominant-negative effects
      on wild-type current.
    explanation: >-
      This supports a dominant-negative HCN4 loss-of-function mechanism for
      familial sinus node dysfunction.
  downstream:
  - target: Bradyarrhythmia and Hypoperfusion
    description: >-
      Reduced pacemaker current slows sinoatrial node firing and can produce
      sinus bradycardia, pauses, and hypoperfusion symptoms.
- name: SCN5A Sodium Current Loss of Function
  conforms_to: "cardiac_ion_channel_repolarization#Cardiac Ion-Channel or Calcium-Handling Variant"
  role: trigger
  description: >-
    SCN5A variants reduce Nav1.5 sodium current through gating, trafficking, or
    temperature-sensitive loss-of-function mechanisms, lowering myocardial
    excitability and impairing cardiac conduction in familial or congenital sick
    sinus syndrome.
  cell_types:
  - preferred_term: cardiac muscle cell
    term:
      id: CL:0000746
      label: cardiac muscle cell
  - preferred_term: cardiac pacemaker cell of sinoatrial node
    term:
      id: CL:1000477
      label: cardiac pacemaker cell of sinoatrial node
  molecular_functions:
  - preferred_term: monoatomic ion channel activity
    term:
      id: GO:0005216
      label: monoatomic ion channel activity
    modifier: ABNORMAL
  biological_processes:
  - preferred_term: cardiac conduction
    term:
      id: GO:0061337
      label: cardiac conduction
    modifier: DECREASED
  - preferred_term: cardiac muscle cell action potential involved in contraction
    term:
      id: GO:0086002
      label: cardiac muscle cell action potential involved in contraction
    modifier: DECREASED
  locations:
  - preferred_term: heart
    term:
      id: UBERON:0000948
      label: heart
  evidence:
  - reference: PMID:14523039
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Probands from three kindreds exhibited compound heterozygosity for six
      distinct SCN5A alleles, including two mutations previously associated with
      dominant disorders of cardiac excitability.
    explanation: >-
      This identifies compound heterozygous SCN5A alleles in pediatric
      congenital sick sinus syndrome kindreds.
  - reference: PMID:14523039
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Biophysical characterization of the mutants using heterologously expressed
      recombinant human heart sodium channels demonstrate loss of function or
      significant impairments in channel gating (inactivation) that predict
      reduced myocardial excitability.
    explanation: >-
      Functional channel assays directly support reduced sodium-channel
      excitability as a mechanism.
  - reference: PMID:34348284
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      At body temperature, Nav1.5-G1712S additionally exhibited an enhanced slow
      inactivation and an impaired recovery from inactivation.
    explanation: >-
      This provides variant-level evidence for temperature-sensitive Nav1.5
      gating defects in a family with sick sinus syndrome and conduction
      disease.
  downstream:
  - target: Bradyarrhythmia and Hypoperfusion
    description: >-
      Sodium-current loss of function can impair impulse initiation or
      propagation, leading to bradyarrhythmia and symptomatic pauses.
- name: Bradyarrhythmia and Hypoperfusion
  role: consequence
  description: >-
    Reduced sinoatrial node firing or conduction produces sinus bradycardia,
    sinus arrest, sinoatrial exit block, chronotropic incompetence, and
    alternating bradycardia-tachycardia syndrome; symptoms arise when pauses or
    slow rates reduce cerebral or systemic perfusion.
  biological_processes:
  - preferred_term: cardiac conduction
    term:
      id: GO:0061337
      label: cardiac conduction
    modifier: DECREASED
  evidence:
  - reference: PMID:37194974
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      SAN dysfunction (SND) can cause complex cardiac arrhythmias that can
      manifest as severe sinus bradycardia, sinus arrest, chronotropic
      incompetence and increased susceptibility to atrial fibrillation, among
      other cardiac conditions.
    explanation: >-
      This review links sinoatrial node dysfunction to the major rhythm
      manifestations curated for familial sick sinus syndrome.
  - reference: PMID:34383451
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Clinical symptoms result from the hypoperfusion of end organs.
    explanation: >-
      This supports hypoperfusion as the downstream symptom mechanism of
      clinically significant bradyarrhythmia.
  downstream:
  - target: Syncope and Sudden Cardiac Death
    description: >-
      Severe bradycardia, sinus pauses, or asystole reduce cerebral perfusion,
      producing syncope and the risk of asystolic sudden death.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - sinus pauses and asystole
    - cerebral hypoperfusion
- name: Syncope and Sudden Cardiac Death
  conforms_to: "cardiac_ion_channel_repolarization#Syncope and Sudden Cardiac Death"
  role: outcome
  description: >-
    Loss of effective cardiac output from severe bradyarrhythmia, prolonged
    sinus pauses, or asystole causes transient cerebral hypoperfusion (syncope
    and presyncope) and, when a pause does not terminate, carries a risk of
    asystolic sudden cardiac death. In familial sick sinus syndrome these
    bradyarrhythmic events are the shared clinical endpoint, and in pedigrees
    with cardiomyopathy overlap (for example LMNA disease) sudden death is part
    of the familial phenotype.
  evidence:
  - reference: PMID:34383451
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      About 50% of patients present with cerebral hypoperfusion (e.g., syncope,
      presyncope, lightheadedness, cerebrovascular accident).
    explanation: >-
      Supports syncope and presyncope as the cerebral-hypoperfusion endpoint of
      bradyarrhythmia in sinus node dysfunction.
  - reference: PMID:27182706
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The proband is a 63-year-old male with a family history of individuals
      (>10) with sinus node dysfunction, ventricular arrhythmia, cardiomyopathy,
      heart failure, and sudden death.
    explanation: >-
      A multigenerational familial sick sinus syndrome pedigree documents sudden
      death as part of the inherited phenotype, supporting it as the terminal
      outcome of the cascade.
phenotypes:
- name: Bradycardia
  category: Cardiovascular
  phenotype_term:
    preferred_term: Bradycardia
    term:
      id: HP:0001662
      label: Bradycardia
  evidence:
  - reference: PMID:34383451
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Electrocardiography findings include sinus bradycardia, sinus pauses or
      arrest, sinoatrial exit block, chronotropic incompetence, or alternating
      bradycardia and tachycardia (i.e., bradycardia-tachycardia syndrome).
    explanation: >-
      Bradycardia is listed as a core ECG manifestation of sinus node
      dysfunction.
- name: Sinus Pauses or Sinoatrial Exit Block
  category: Cardiovascular
  phenotype_term:
    preferred_term: abnormal electrophysiology of sinoatrial node origin
    term:
      id: HP:0011702
      label: Abnormal electrophysiology of sinoatrial node origin
  evidence:
  - reference: PMID:34383451
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Electrocardiography findings include sinus bradycardia, sinus pauses or
      arrest, sinoatrial exit block, chronotropic incompetence, or alternating
      bradycardia and tachycardia (i.e., bradycardia-tachycardia syndrome).
    explanation: >-
      The review explicitly lists sinus pauses or arrest and sinoatrial exit
      block as ECG manifestations.
- name: Chronotropic Incompetence
  category: Cardiovascular
  phenotype_term:
    preferred_term: Chronotropic incompetence
    term:
      id: HP:0003546
      label: Exercise intolerance
  evidence:
  - reference: PMID:34383451
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The patient's inability to reach a heart rate of at least 80% of their
      predicted maximum (220 beats per minute - age) may indicate chronotropic
      incompetence, which is present in 50% of patients with sinus node
      dysfunction.
    explanation: >-
      Chronotropic incompetence is explicitly described as a common functional
      consequence of sinus node dysfunction; the available HPO term captures the
      exercise-intolerance manifestation.
- name: Syncope or Presyncope
  category: Neurologic
  phenotype_term:
    preferred_term: Syncope
    term:
      id: HP:0001279
      label: Syncope
  evidence:
  - reference: PMID:34383451
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      About 50% of patients present with cerebral hypoperfusion (e.g., syncope,
      presyncope, lightheadedness, cerebrovascular accident).
    explanation: >-
      Syncope and presyncope are direct manifestations of cerebral hypoperfusion
      in sinus node dysfunction.
- name: Palpitations
  category: Cardiovascular
  phenotype_term:
    preferred_term: Palpitations
    term:
      id: HP:0001962
      label: Palpitations
  evidence:
  - reference: PMID:34383451
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Other symptoms include palpitations, decreased physical activity
      tolerance, angina, muscular fatigue, or oliguria.
    explanation: >-
      Palpitations are listed among symptomatic presentations of sinus node
      dysfunction.
- name: Atrial Fibrillation
  category: Cardiovascular
  phenotype_term:
    preferred_term: Atrial fibrillation
    term:
      id: HP:0005110
      label: Atrial fibrillation
  evidence:
  - reference: PMID:37194974
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      SAN dysfunction (SND) can cause complex cardiac arrhythmias that can
      manifest as severe sinus bradycardia, sinus arrest, chronotropic
      incompetence and increased susceptibility to atrial fibrillation, among
      other cardiac conditions.
    explanation: >-
      Familial sick sinus syndrome can include increased atrial fibrillation
      susceptibility as part of the sinoatrial-node dysfunction spectrum.
- name: Left ventricular noncompaction
  category: Cardiovascular
  phenotype_term:
    preferred_term: Left ventricular noncompaction
    term:
      id: HP:0030682
      label: Left ventricular noncompaction
  evidence:
  - reference: PMID:25145517
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Subsequent screening of HCN4 in 3 additional families with the same
      clinical combination of bradycardia and LVNC identified HCN4 mutations in
      each.
    explanation: >-
      HCN4-related familial sick sinus syndrome is reported with left ventricular
      noncompaction in multiple families.
- name: Fatigue
  category: Constitutional
  phenotype_term:
    preferred_term: Fatigue
    term:
      id: HP:0012378
      label: Fatigue
  evidence:
  - reference: PMID:34383451
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Other symptoms include palpitations, decreased physical activity
      tolerance, angina, muscular fatigue, or oliguria.
    explanation: >-
      Muscular fatigue is listed among symptoms of sinus node dysfunction.
genetic:
- name: HCN4 loss-of-function variants
  association: Causative
  gene_term:
    preferred_term: HCN4
    term:
      id: hgnc:16882
      label: HCN4
  features: >-
    HCN4 variants cause familial sinus bradycardia or sinus node dysfunction,
    sometimes with left ventricular noncompaction cardiomyopathy.
  evidence:
  - reference: PMID:25145517
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Familial forms of primary sinus bradycardia have sometimes been attributed
      to mutations in HCN4, SCN5A, and ANK2.
    explanation: >-
      This review of familial bradycardia pedigrees identifies HCN4 as one of
      the established familial sinus-bradycardia genes.
  - reference: PMID:25145517
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Subsequent screening of HCN4 in 3 additional families with the same
      clinical combination of bradycardia and LVNC identified HCN4 mutations in
      each.
    explanation: >-
      Multiple families with the combined bradycardia phenotype had HCN4
      mutations.
- name: SCN5A loss-of-function variants
  association: Causative
  gene_term:
    preferred_term: SCN5A
    term:
      id: hgnc:10593
      label: SCN5A
  features: >-
    SCN5A loss-of-function can cause congenital or familial sick sinus syndrome,
    including compound-heterozygous recessive disease and overlap presentations
    with Brugada syndrome or cardiac conduction disease.
  evidence:
  - reference: PMID:14523039
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Based on prior associations with disorders of cardiac rhythm and
      conduction, we screened the alpha subunit of the cardiac sodium channel
      (SCN5A) as a candidate gene in ten pediatric patients from seven families
      who were diagnosed with congenital SSS during the first decade of life.
    explanation: >-
      This supports SCN5A as a candidate and confirmed disease gene in
      pediatric congenital sick sinus syndrome kindreds.
  - reference: PMID:34348284
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We conclude that G1712S is a pathogenic SCN5A loss-of function mutation at
      physiological temperature associated with an overlapping presentation of
      BrS, SSS, and cardiac conduction disease.
    explanation: >-
      This family report supports SCN5A loss-of-function as a contributor to
      symptomatic sick sinus syndrome and conduction disease.
- name: ANK2-associated susceptibility
  association: Causative
  gene_term:
    preferred_term: ANK2
    term:
      id: hgnc:493
      label: ANK2
  features: >-
    ANK2 is a reported familial primary sinus bradycardia gene within the broader
    sick sinus syndrome genetic architecture.
  evidence:
  - reference: PMID:25145517
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Familial forms of primary sinus bradycardia have sometimes been attributed
      to mutations in HCN4, SCN5A, and ANK2.
    explanation: >-
      The HCN4 family paper names ANK2 alongside HCN4 and SCN5A as a familial
      primary sinus bradycardia gene.
- name: LMNA splice-site variants
  association: Causative
  gene_term:
    preferred_term: LMNA
    term:
      id: hgnc:6636
      label: LMNA
  features: >-
    LMNA disease can present with familial sick sinus syndrome together with
    dilated cardiomyopathy, ventricular arrhythmia, heart failure, and sudden
    cardiac death.
  evidence:
  - reference: PMID:27182706
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The proband is a 63-year-old male with a family history of individuals
      (>10) with sinus node dysfunction, ventricular arrhythmia, cardiomyopathy,
      heart failure, and sudden death.
    explanation: >-
      This describes a multigenerational familial sick sinus syndrome pedigree
      with cardiomyopathy and sudden-death overlap.
  - reference: PMID:27182706
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The results identified LMNA c.357-2A>G, a novel heterozygous splice-site
      mutation as the primary mutation with rare or novel variants in HCN4,
      MYBPC3, PKP4, TMPO, TTN, DMPK and KCNJ10 as potential modifiers and a
      mechanism consistent with haploinsufficiency.
    explanation: >-
      Exome sequencing identified an LMNA splice-site mutation as the primary
      familial variant with additional possible modifiers.
- name: KRT8 p.Gly62Cys susceptibility variant
  association: Risk Factor
  gene_term:
    preferred_term: KRT8
    term:
      id: hgnc:6446
      label: KRT8
  features: >-
    Population-scale association supports KRT8 p.Gly62Cys as a low-frequency
    susceptibility variant with particularly high risk in homozygotes.
  evidence:
  - reference: PMID:33580673
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report the associations of variants at six loci with SSS, including a
      missense variant in KRT8 that confers high risk in homozygotes and points
      to a mechanism specific to SSS development.
    explanation: >-
      The GWAS/meta-analysis supports KRT8 as a sick sinus syndrome risk locus
      rather than a classic Mendelian familial gene.
- name: MYH6-associated susceptibility
  association: Risk Factor
  gene_term:
    preferred_term: MYH6
    term:
      id: hgnc:7576
      label: MYH6
  features: >-
    MYH6 variation is represented among population-level sick sinus syndrome
    risk loci and may contribute to atrial or sinoatrial node susceptibility.
  evidence:
  - reference: PMID:33580673
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Variants at six loci associated with SSS, a reported missense variant in
      MYH6, known atrial fibrillation (AF)/electrocardiogram variants at PITX2,
      ZFHX3, TTN/CCDC141, and SCN10A and a low-frequency (MAF = 1.1-1.8%)
      missense variant, p.Gly62Cys in KRT8 encoding the intermediate filament
      protein keratin 8.
    explanation: >-
      This supports MYH6 as part of the broader sick sinus syndrome genetic risk
      architecture.
environmental:
- name: Reversible extrinsic contributors to sinus node dysfunction
  notes: >-
    Familial sick sinus syndrome is primarily genetic, but medications,
    metabolic abnormalities, and other extrinsic contributors should be excluded
    or corrected because they can mimic or worsen sinoatrial node dysfunction.
  evidence:
  - reference: PMID:34383451
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The causes of sinus node dysfunction are intrinsic (e.g., degenerative
      idiopathic fibrosis, cardiac remodeling) or extrinsic (e.g., medications,
      metabolic abnormalities) to the sinoatrial node.
    explanation: >-
      This supports reversible extrinsic contributors as differential or
      modifying factors rather than the primary familial cause.
diagnosis:
- name: ECG and ambulatory rhythm monitoring
  description: >-
    Diagnosis is based on correlating symptoms with bradyarrhythmia using
    electrocardiography, ambulatory rhythm monitoring, and exercise testing when
    exertional symptoms suggest chronotropic incompetence.
  evidence:
  - reference: PMID:34383451
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A diagnosis is made by directly correlating symptoms with a
      bradyarrhythmia and eliminating potentially reversible extrinsic causes.
    explanation: >-
      This states the diagnostic principle for sinus node dysfunction.
  - reference: PMID:34383451
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Heart rate monitoring using electrocardiography or ambulatory cardiac
      event monitoring is performed based on the frequency of symptoms.
    explanation: >-
      This supports ECG or ambulatory monitoring as the main diagnostic testing
      approach.
- name: Genetic testing for familial sick sinus syndrome genes
  description: >-
    Exome sequencing or multigene arrhythmia/cardiomyopathy panels can identify
    pathogenic familial variants and candidate modifiers when a familial pattern
    or cardiomyopathy overlap is present.
  diagnosis_term:
    preferred_term: genetic testing
    term:
      id: MAXO:0000127
      label: genetic testing
  evidence:
  - reference: PMID:27182706
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We used exome sequencing of a single individual to identify a novel LMNA
      mutation and demonstrated the importance of Sanger validation and family
      studies when evaluating candidates.
    explanation: >-
      This familial sick sinus syndrome pedigree used exome sequencing followed
      by validation and family studies to identify the primary LMNA mutation.
treatments:
- name: Permanent Pacemaker Implantation
  description: >-
    Permanent pacemaker therapy is the main established treatment for confirmed,
    symptomatic sinus node dysfunction with clinically significant bradycardia
    or pauses; current therapy does not correct the underlying genetic mechanism.
  treatment_term:
    preferred_term: pacemaker implantation
    term:
      id: MAXO:0009034
      label: pacemaker implantation
  evidence:
  - reference: PMID:34383451
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      First-line treatment for patients with confirmed sinus node dysfunction is
      permanent pacemaker placement with atrial-based pacing and limited
      ventricular pacing when necessary.
    explanation: >-
      This supports pacemaker implantation as first-line treatment for confirmed
      symptomatic sinus node dysfunction.
  - reference: PMID:38667717
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In sinus node dysfunction, symptomatic bradycardia is the most relevant
      recommendation for pacing.
    explanation: >-
      Pediatric CIED guideline review supports symptom-correlated bradycardia as
      the key pacing indication.
notes: >-
  Falcon deep research completed on 2026-05-09 and was used to select the core
  SAN genetics, HCN4, SCN5A, LMNA, GWAS, clinical diagnosis, and pacemaker
  evidence. Verkerk 2023 and other non-PubMed-accessible citations were retained
  in the research artifact but not used as YAML evidence because PMID-backed
  abstract snippets were preferred for validation.

📚

References & Deep Research

Deep Research

1

Falcon ▸

Familial Sick Sinus Syndrome (Familial Sinus Node Dysfunction): Disease Characteristics Research Report

Edison Scientific Literature 30 citations 2026-05-09T08:56:59.060705

Familial Sick Sinus Syndrome (Familial Sinus Node Dysfunction): Disease Characteristics Research Report

Target Disease

Disease name: Familial Sick Sinus Syndrome (Familial SSS) / Familial Sinus Node Dysfunction (Familial SND)
Category: Genetic (familial inherited bradyarrhythmia / conduction disorder)

Executive overview

Familial sick sinus syndrome is an inherited predisposition to sinoatrial node dysfunction (SND)—a disorder of cardiac impulse formation and/or propagation from the sinoatrial node that can manifest as sinus bradycardia, sinus pauses/arrest, sinoatrial exit block, chronotropic incompetence, and tachycardia–bradycardia syndrome (often with atrial fibrillation). While SND/SSS is commonly age-related, heritable genetic variation contributes to earlier-onset or syndromic forms and to risk in the general population. Contemporary reviews emphasize that there is no established therapy that corrects underlying molecular causes, and management remains largely device-based (pacemakers). (maarel2023geneticsofsinoatrial pages 1-2, li2024cardiacconductiondiseases pages 3-4)

1. Disease Information

1.1 What is the disease?

SSS is described as a complex arrhythmia “characterized by pathological sinus bradycardia, sinoatrial block, or alternating atrial brady- and tachyarrhythmias” and is a leading indication for permanent pacing. (thorolfsdottir2021geneticinsightinto pages 2-3)
Recent mechanistic reviews summarize SND as abnormalities of SAN impulse formation/propagation manifesting as sinus bradycardia, sinus pauses, SAN exit block, and tachycardia–bradycardia syndrome. (li2024cardiacconductiondiseases pages 3-4)

Direct quote (definition): “SSS is … characterized by pathological sinus bradycardia, sinoatrial block, or alternating atrial brady- and tachyarrhythmias.” (thorolfsdottir2021geneticinsightinto pages 2-3)

1.2 Key identifiers (available from retrieved evidence)

ICD-10: I49.5 (sick sinus syndrome) (referenced as coding context and diagnosis code for SSS in retrieved materials). (iskenderov2023familialformof pages 1-3)
OMIM: SSS1 (OMIM 608567) is referenced as SCN5A-related sick sinus syndrome in the context of SCN5A-associated inherited arrhythmia phenotypes. (iskenderov2023familialformof pages 1-3)

Not available in retrieved evidence: MONDO ID, Orphanet ID, MeSH ID (would require direct database queries beyond the currently retrieved full texts).

1.3 Common synonyms / alternative names

Sick sinus syndrome (SSS)
Sinus node dysfunction (SND)
Sinoatrial node dysfunction
Familial sinus bradycardia (subset phenotype)

The 2023 review notes ICD-11 “sinus node dysfunction” as a broader term than SSS. (iskenderov2023familialformofa pages 1-3)

1.4 Evidence sources

The report is derived from: - Aggregated disease-level reviews (2023–2024) and guideline summaries (pediatric CIED pacing). (maarel2023geneticsofsinoatrial pages 1-2, li2024cardiacconductiondiseases pages 3-4, silvetti2024newguidelinesof pages 1-2) - Primary human genetics (large GWAS/meta-analysis; family exome sequencing; family phenotype/genotype studies). (thorolfsdottir2021geneticinsightinto pages 2-3, zaragoza2016exomesequencingidentifies pages 1-2, schweizer2014thesymptomcomplex pages 1-2) - Functional in vitro and in silico modeling of variants (HCN4). (verkerk2023functionalcharacterizationof pages 1-2)

2. Etiology

2.1 Disease causal factors

Primary cause (familial disease): germline genetic variants affecting sinoatrial node pacemaking and atrial conduction biology.

Recent reviews categorize causal mechanisms into: - Membrane clock (“M-clock”) perturbations (If, ICaL/ICaT, IK, NCX, INa) - Intracellular Ca2+ clock perturbations (SR Ca2+ release/buffering) - Structural/trafficking/nuclear envelope mechanisms (e.g., ankyrin-B, lamin A/C)

These are summarized in 2024 conduction-system review: SAN automaticity arises from coupling of “M clock” and “Ca2+ clock.” (li2024cardiacconductiondiseases pages 3-4)

2.2 Risk factors

Genetic risk factors

Rare familial variants: HCN4, SCN5A, GNB2 and others have been reported in familial disease. (thorolfsdottir2021geneticinsightinto pages 2-3, li2024cardiacconductiondiseases pages 3-4)
Common/low-frequency population risk: a low-frequency KRT8 p.Gly62Cys variant shows large genotype-dependent risk in a major GWAS/meta-analysis (heterozygote OR 1.44; homozygote OR 13.99). (thorolfsdottir2021geneticinsightinto pages 2-3)

Non-genetic / clinical risk factors

Age is described as “the strongest risk factor” in a large human genetics study. (thorolfsdottir2021geneticinsightinto pages 2-3)
Secondary (acquired) contributors noted in the 2023 familial SSS review include medications and electrolyte abnormalities (e.g., hyperkalemia, hypercalcemia). (iskenderov2023familialformof pages 1-3)

Causal inference from human genetics

Mendelian randomization in the 2021 EHJ study supported a causal role for atrial fibrillation (AF) and lower heart rate in SSS development, while arguing against causal associations for BMI, cholesterol, triglycerides and type 2 diabetes. (thorolfsdottir2021geneticinsightinto pages 2-3)

2.3 Protective factors

No specific protective genetic variants or lifestyle protective factors were identified in the retrieved evidence. The MR analysis arguing against causality for BMI/lipids/T2D should not be interpreted as protective. (thorolfsdottir2021geneticinsightinto pages 2-3)

2.4 Gene–environment interactions

The 2024 review describes strong autonomic modulation of SAN rate (sympathetic vs parasympathetic) and notes vagal tone can accentuate bradycardia in pacemaker-current impairment; in modeling, HCN4 A414G–related bradycardia becomes more prominent under vagal tone. (verkerk2023functionalcharacterizationof pages 1-2, li2024cardiacconductiondiseases pages 3-4)

3. Phenotypes

3.1 Core phenotype set (with suggested HPO terms)

Below are key familial SSS/SND manifestations supported by the retrieved literature.

Sinus bradycardia (symptom/sign)
Suggested HPO: HP:0001388 (Bradycardia)
SAN dysfunction yields bradycardia with P-wave rate < ~60/min as an ECG correlate described in a 2023 genetics review. (maarel2023geneticsofsinoatrial pages 2-3)
Sinus arrest / sinus pauses (sign; ECG/Holter abnormality)
Suggested HPO: HP:0030637 (Sinus arrest) (term suggestion; exact HPO mapping should be verified)
Included in SND manifestations in 2023–2024 reviews. (maarel2023geneticsofsinoatrial pages 1-2, li2024cardiacconductiondiseases pages 3-4)
Sinoatrial exit block (ECG abnormality)
Suggested HPO: HP:0011700 (Sinoatrial block) (term suggestion; verify in HPO)
Absence of a P wave at expected intervals described as SAN exit block. (maarel2023geneticsofsinoatrial pages 2-3)
Chronotropic incompetence (functional abnormality)
Suggested HPO: HP:0031645 (Chronotropic incompetence) (term suggestion; verify)
Explicitly described as an SND manifestation and used as pacing-indication criterion in pediatric guidelines (symptoms temporally associated with chronotropic incompetence). (maarel2023geneticsofsinoatrial pages 1-2, silvetti2024newguidelinesof pages 2-4)
Tachycardia–bradycardia syndrome / AF susceptibility
Suggested HPO: HP:0005110 (Atrial fibrillation); HP:0005111 (Atrial flutter)
Familial SSS review reports tachy-brady syndrome in ≥50% of cases and describes AF as part of the syndrome spectrum. (iskenderov2023familialformof pages 1-3)
Syncope / dizziness due to cerebral hypoperfusion
Suggested HPO: HP:0001279 (Syncope); HP:0002321 (Vertigo) or dizziness term (verify)
The 2023 review reports about 50% of patients have symptoms of cerebral hypoperfusion (dizziness, syncope). (iskenderov2023familialformof pages 1-3)

3.2 Temporal features (onset and progression)

SND/SSS commonly peaks in the 70–80-year range for sporadic disease. (li2024cardiacconductiondiseases pages 3-4)
Familial disease includes congenital/childhood or early-onset presentations (e.g., SCN5A/HCN4 and syndromic LMNA pedigrees). (zaragoza2016exomesequencingidentifies pages 1-2, iskenderov2023familialformofa pages 1-3)

3.3 Quality of life impact

Direct QoL instrument data (e.g., SF-36/EQ-5D) in familial SSS specifically were not retrieved in available full texts. However, symptoms (syncope, fatigue, exercise intolerance from chronotropic incompetence) and device dependence imply substantial impact; this is indirectly supported by pacing guideline emphasis on symptom correlation. (silvetti2024newguidelinesof pages 2-4, silvetti2024newguidelinesof pages 1-2)

4. Genetic / Molecular Information

4.1 Causal genes (high-confidence in retrieved evidence)

Recent expert reviews list familial SND genes across M-clock, Ca2+-clock, and structural/trafficking categories, including HCN4, SCN5A, KCNJ5, GNB2, CACNA1D, RYR2, CASQ2, ANK2, GJC1, MYH6. (li2024cardiacconductiondiseases pages 3-4)

A 2023 SAN genetics review additionally highlights Mendelian genes such as GNB5 (AR multisystem syndrome with bradycardia) and notes HCN4 and SCN5A as recurrent candidates. (maarel2023geneticsofsinoatrial pages 14-15)

4.2 Pathogenic variants and functional consequences (examples)

HCN4 A414G (heterozygous LoF): causes a large negative shift in activation (V1/2) and slowed gating, translating in a human SAN cell model to increased cycle length (bradycardia), especially under vagal tone. Quantitatively: V1/2 −19.9 mV, time constant shift −11.9 mV (both p<0.001). (verkerk2023functionalcharacterizationof pages 1-2)
HCN4 dominant-negative LoF: HCN4-G482R and other variants in familial SND + LV noncompaction; mutant subunits can be nonfunctional and exert dominant-negative effects on WT current (family study). (schweizer2014thesymptomcomplex pages 1-2)
SCN5A loss of function: Familial SSS linked to SCN5A; mechanisms include altered kinetics, impaired trafficking, or complete non-functionality across a panel of 13 familial-SSS-linked Nav1.5 mutants in a dedicated mechanistic study. (li2024cardiacconductiondiseases pages 3-4)
LMNA splice-site (c.357-2A>G): identified by exome sequencing in a family with SSS, dilated cardiomyopathy and sudden death; fibroblast data consistent with haploinsufficiency (monoallelic expression of normal allele). (zaragoza2016exomesequencingidentifies pages 1-2)

4.3 Modifier genes / oligogenicity

Oligogenic burden is suggested by: - LMNA family study reporting additional rare variants in genes including HCN4, TTN, etc. as potential modifiers. (zaragoza2016exomesequencingidentifies pages 1-2) - 2023 familial SSS review emphasizes “polygenic origin” and genetic heterogeneity. (iskenderov2023familialformofa pages 1-3)

4.4 Epigenetic information

No familial SSS-specific epigenetic profiling evidence was retrieved in the current evidence set.

4.5 Chromosomal abnormalities

No chromosomal abnormality evidence was retrieved.

5. Environmental Information

Familial SSS is primarily genetic, but secondary SSS can result from exogenous factors. The 2023 review lists medications and electrolyte disturbances (hyperkalemia/hypercalcemia) as causes of secondary SSS. (iskenderov2023familialformof pages 1-3)

No infectious triggers were identified in retrieved evidence.

6. Mechanism / Pathophysiology

6.1 Conceptual model (upstream → downstream causal chain)

Genetic variant in pacemaker ion channel / Ca2+ handling / structural scaffolding / nuclear envelope gene
Cellular electrophysiology defect in SAN pacemaker cells:
If impairment (HCN4 LoF) → slower diastolic depolarization, longer cycle length; vagal tone can exacerbate effect (modeling). (verkerk2023functionalcharacterizationof pages 1-2)
Membrane clock/Ca2+ clock uncoupling (review). (li2024cardiacconductiondiseases pages 3-4)
Sodium current reduction (SCN5A LOF) → impaired impulse initiation/propagation (reviewed). (li2024cardiacconductiondiseases pages 3-4)
Tissue/organ-level phenotype: SAN exit block, bradycardia, pauses; atrial remodeling and susceptibility to AF; potential overlap with cardiomyopathy (LMNA). (li2024cardiacconductiondiseases pages 3-4, zaragoza2016exomesequencingidentifies pages 1-2)

6.2 Molecular pathways and processes (with ontology suggestions)

GO Biological Process (suggestions):
regulation of heart rate
cardiac muscle cell action potential
sinoatrial node cell development/differentiation
regulation of membrane depolarization
Key mechanistic themes from 2024 review: coupling of M-clock (ICaL, ICaT, IK, If, NCX) with Ca2+ clock (SR Ca2+ release via RyR2). (li2024cardiacconductiondiseases pages 3-4)

6.3 Cell types (CL term suggestions)

Sinoatrial node pacemaker cardiomyocyte (CL term suggestion; exact CL ID requires ontology lookup)

6.4 Tissue and anatomy (UBERON suggestions)

Sinoatrial node (UBERON term suggestion)
Right atrium (UBERON term suggestion)

The 2023 SAN genetics review describes the SAN as a small structure of thousands of pacemaker cardiomyocytes at the junction of venous return and right atrium. (maarel2023geneticsofsinoatrial pages 2-3)

6.5 Advanced molecular profiling

No transcriptomic/proteomic/metabolomic disease signatures were directly retrieved for familial SSS in this evidence set.

7. Anatomical Structures Affected

Primary organ/system: Heart; cardiac conduction system (SAN; atrial conduction)
Secondary involvement: atria (AF risk); overlap cardiomyopathy/conduction disease in LMNA pedigrees (dilated cardiomyopathy, SCD). (zaragoza2016exomesequencingidentifies pages 1-2)

8. Temporal Development

Typical sporadic onset: later adulthood; incidence peak ~70–80 years. (li2024cardiacconductiondiseases pages 3-4)
Familial onset: can be congenital/pediatric/young adult; genotype-dependent (e.g., channelopathies, LMNA). (zaragoza2016exomesequencingidentifies pages 1-2)
Course: often progressive and complicated by atrial arrhythmias; device dependence develops when symptomatic or high-risk pauses occur.

9. Inheritance and Population

9.1 Inheritance patterns

Familial SSS includes both autosomal dominant and autosomal recessive inheritance patterns depending on gene/variant class (e.g., HCN4 commonly AD; SCN5A can be recessive in congenital forms). (iskenderov2023familialformofa pages 6-7)

9.2 Epidemiology and statistics

From the 2023 familial SSS review: - Overall annual incidence: ~1 per 1,000 in people ≥45 years. (iskenderov2023familialformof pages 1-3) - In heart disease patients >65: 1 in 600. (iskenderov2023familialformof pages 1-3) - Age- and race-standardized rates: 0.8 and 0.9 per 1,000 person-years in women and men. (iskenderov2023familialformof pages 1-3)

From the large human genetics study: - Study size: meta-analysis included 6,189 cases in one excerpt and ~6,469 in abstract (depending on excerpted sections), and large control populations, highlighting that SSS has both rare familial and polygenic components. (thorolfsdottir2021geneticinsightinto pages 2-3)

9.3 Penetrance/expressivity and modifiers

Incomplete penetrance/modification is highlighted for ANK2-related disease and in oligogenic pedigrees. (iskenderov2023familialformofa pages 6-7, zaragoza2016exomesequencingidentifies pages 1-2)
Strong genotype effect in KRT8 p.Gly62Cys shows substantial risk increase in homozygotes (OR 13.99). (thorolfsdottir2021geneticinsightinto pages 2-3)

10. Diagnostics

10.1 Clinical tests

ECG / rhythm monitoring is central. The 2023 familial SSS review states diagnosis remains primarily electrocardiographic. (iskenderov2023familialformof pages 1-3)
The 2023 SAN genetics review describes ECG correlates: P-wave reflects SAN-initiated atrial activation; SAN dysfunction yields bradycardia, exit block (missing P wave at expected times), and ectopic atrial activation (altered P-wave morphology). (maarel2023geneticsofsinoatrial pages 2-3)
Holter / longer-term monitoring: used to quantify pauses and relate symptoms to rhythm; explicitly used as outcome in pacing trials in CHD with SND. (NCT03361189 chunk 2)

10.2 Genetic testing strategy (real-world approach)

Given genetic heterogeneity across ion channels, Ca2+ handling, and structural genes, recent clinical reviews suggest that single-gene testing is often insufficient and that multi-gene panels and/or exome sequencing may be needed—illustrated by: - Exome sequencing to identify LMNA splice-site mutation plus candidate modifiers in a large pedigree. (zaragoza2016exomesequencingidentifies pages 1-2) - Reviews cataloging multiple gene classes for familial SND. (li2024cardiacconductiondiseases pages 3-4)

10.3 Differential diagnosis

Not systematically enumerated in retrieved evidence; however, secondary causes (drugs/electrolytes) should be excluded when diagnosing familial primary SSS. (iskenderov2023familialformof pages 1-3)

11. Outcomes / Prognosis

Disease-specific survival statistics for familial SSS were not retrieved. However: - LMNA pedigrees demonstrate association with dilated cardiomyopathy and sudden cardiac death, indicating gene-specific higher-risk trajectories and need for structured surveillance. (zaragoza2016exomesequencingidentifies pages 1-2) - The 2023 familial SSS review associates SSS with increased risk of sudden cardiac death and emphasizes current management is symptom relief. (iskenderov2023familialformofa pages 1-3)

12. Treatment

12.1 Standard of care: cardiac pacing

Multiple sources agree that management is primarily device-based: - 2023 SAN genetics review notes no molecularly targeted therapy; management relies mainly on permanent electronic pacemaker implantation. (maarel2023geneticsofsinoatrial pages 1-2) - 2023 familial SSS review reports pacemaker implantation is indicated in ~30–50% of cases in Europe/USA. (iskenderov2023familialformof pages 1-3)

12.2 Pediatric pacing guideline evidence (2024)

Silvetti et al. (J Cardiovasc Dev Dis. Mar 2024, DOI: https://doi.org/10.3390/jcdd11040099) summarize pediatric consensus guidance: - For isolated SND, symptom correlation is central: - Class I: SND with symptoms correlated with age-inappropriate bradycardia (pacing indicated). (silvetti2024newguidelinesof pages 2-4) - Class IIa: symptoms temporally associated with chronotropic incompetence → rate-responsive pacemaker indicated. (silvetti2024newguidelinesof pages 2-4) - Device strategy highlights preferential atrial/dual chamber pacing and rate-responsive sensors to promote physiologic response. (silvetti2024newguidelinesof pages 4-5)

12.3 Emerging approaches / expert opinion

Recent expert opinion emphasizes research directions rather than established therapies: - Need for “genotype-targeted pharmacotherapy” and “biological pacemaker” development is emphasized in the 2023 familial SSS review. (iskenderov2023familialformof pages 9-10)

12.4 MAXO suggestions

Permanent pacemaker implantation (MAXO term suggestion; requires ontology lookup)
Implantable loop recorder insertion (MAXO term suggestion)

13. Prevention

Primary prevention (genetic): cascade family screening and surveillance is implied by inherited-arrhythmia guidance emphasizing relatives’ screening; pediatric guideline summary notes loop recorders may help guide management of inherited arrhythmia syndromes. (silvetti2024newguidelinesof pages 1-2)
Secondary/tertiary prevention: avoid reversible/secondary causes (medications, electrolyte abnormalities) and treat symptomatic bradycardia/pauses with pacing. (iskenderov2023familialformof pages 1-3, silvetti2024newguidelinesof pages 2-4)

14. Other Species / Natural Disease

No naturally occurring veterinary disease evidence was retrieved in the current evidence set.

15. Model Organisms and Experimental Models

2023 SAN genetics review notes Hcn4 inactivation in mouse causes severely reduced contraction rates and embryonic lethality (E9.5–E11.5), indicating developmental necessity of pacemaker channel programs. (maarel2023geneticsofsinoatrial pages 2-3)
Functional + computational modeling: HCN4 A414G measured in CHO cells and integrated into a human SAN cell model to explain clinical bradycardia (vagal dependence; atrial load effect). (verkerk2023functionalcharacterizationof pages 1-2)
Reviews highlight mouse models and iPSC-derived SAN cardiomyocytes as key experimental platforms. (maarel2023geneticsofsinoatrial pages 1-2)

Recent developments (prioritizing 2023–2024)

Mechanism integration (M-clock/Ca-clock + heterogeneity): 2024 review emphasizes SAN automaticity arises from integrated “M clock” and “Ca2+ clock” mechanisms and heterogeneous subcellular signaling/cluster interactions (tonic entrainment). (li2024cardiacconductiondiseases pages 3-4)
Functional quantification of HCN4 variant effects: 2023 functional study provides quantitative gating shifts explaining bradycardia and highlights vagal-tone interactions, providing a template for variant interpretation. (verkerk2023functionalcharacterizationof pages 1-2)
Clinical guideline evolution in pediatrics: 2024 guideline summary prioritizes symptom correlation, introduces nuanced Class IIb situations, and points to increased use of physiologic pacing and loop recorders in inherited arrhythmia contexts. (silvetti2024newguidelinesof pages 2-4, silvetti2024newguidelinesof pages 1-2)

Applications and real-world implementation

Electrophysiology practice: ECG/Holter-based diagnosis and long-term management with permanent pacemakers remain the main real-world implementation across age groups. (iskenderov2023familialformof pages 1-3, maarel2023geneticsofsinoatrial pages 1-2)
Genetic cardiology: use of exome sequencing or large arrhythmia panels in familial cases (LMNA pedigree) illustrates current implementation of genomics in diagnosis and cascade screening. (zaragoza2016exomesequencingidentifies pages 1-2)

Expert opinions and authoritative analyses

Expert Opinion on Therapeutic Targets (May 2024) highlights that current treatment for conduction disease manifested as bradycardia still relies primarily on cardiovascular implantable electronic devices, while arguing for translation of mechanistic knowledge to pharmacologic/genetic interventions. (li2024cardiacconductiondiseases pages 3-4)
Disease Models & Mechanisms (May 2023) review emphasizes genetic insights as a path to improved therapeutics but notes present reliance on pacemakers. (maarel2023geneticsofsinoatrial pages 1-2)

Relevant statistics and data (recent/large studies)

KRT8 p.Gly62Cys risk: OR 1.44 (heterozygotes) and OR 13.99 (homozygotes). (thorolfsdottir2021geneticinsightinto pages 2-3)
Epidemiology estimates: incidence ~1/1000/year (≥45), and 0.8–0.9 per 1,000 person-years women/men; pacemaker indicated in 30–50% (Europe/USA). (iskenderov2023familialformof pages 1-3)

Clinical trials / registries (ClinicalTrials.gov)

The following registered studies explicitly relate to genetics/polymorphisms or management/monitoring relevant to SSS/SND: - NCT00314223 (2006; observational case-control): genetic polymorphisms in Taiwanese SSS patients; includes HCN1–4, SCN5A, KCNE and others; prospective. (NCT00314223 chunk 1) - URL: https://clinicaltrials.gov/study/NCT00314223 - NCT01310907 (2011; observational): gene polymorphisms in non-familial bradyarrhythmia (includes sinus node dysfunction and AV block). (NCT01310907 chunk 1) - URL: https://clinicaltrials.gov/study/NCT01310907 - NCT01310920 (2011; observational): angiotensinogen promoter polymorphisms in non-familial SSS. (NCT01310920 chunk 1) - URL: https://clinicaltrials.gov/study/NCT01310920 - NCT03361189 (UCLA; specialized pacing/CLS in CHD with significant SND): evaluates closed-loop stimulation vs standard rate response using stress testing and Holter outcomes; status TERMINATED in search metadata. (NCT03361189 chunk 2) - URL: https://clinicaltrials.gov/study/NCT03361189 - NCT00664807 (GAME Study; completed 2009): genetic/ECG markers for arrhythmia prediction in ICD populations; relevant as a genetic-marker study of arrhythmia risk; includes publication note with PMID 22247754. (NCT00664807 chunk 1) - URL: https://clinicaltrials.gov/study/NCT00664807

Gene-centric summary table

The following table consolidates genes, phenotypes, mechanisms, and evidence types from this evidence set.

Gene	Inheritance pattern / notes	Key phenotype(s)	Mechanistic theme	Evidence type	Key quantitative / statistical details	Citation IDs
HCN4	Usually autosomal dominant in reported families; multiple heterozygous loss-of-function variants reported	Sinus bradycardia, sinus node dysfunction, sinus arrest, chronotropic incompetence, atrial fibrillation; some families also show left ventricular noncompaction	If / pacemaker current dysfunction in sinoatrial node cells	Family studies, functional assay, review	A414G heterozygous current showed −19.9 mV shift in V1/2 and −11.9 mV shift in (de)activation time constant (both p<0.001); mutant channels can act dominant-negatively; HCN4 is described as the predominant human SAN HCN isoform	(schweizer2014thesymptomcomplex pages 1-2, verkerk2023functionalcharacterizationof pages 1-2, maarel2023geneticsofsinoatrial pages 1-2, li2024cardiacconductiondiseases pages 3-4, maarel2023geneticsofsinoatrial pages 14-15)
SCN5A	Familial SSS can be autosomal recessive (classically congenital SSS1) or dominant in some families; compound heterozygous and homozygous cases reported	Congenital/childhood or early-onset sick sinus syndrome, severe bradycardia, sinus pauses/arrest, atrial arrhythmias, overlap with Brugada syndrome / conduction disease	INa / sodium channel loss of function; gating defects and trafficking defects	Family studies, mechanistic functional studies, case reports, review	13 familial SSS-linked Nav1.5 mutants were grouped mechanistically into altered kinetics, impaired trafficking, or non-functional channels; recessive SCN5A cause recognized as SSS1 (OMIM 608567)	(iskenderov2023familialformofa pages 6-7, zaragoza2016exomesequencingidentifies pages 1-2, sanner2021anovelscn5a pages 9-9, li2024cardiacconductiondiseases pages 3-4)
LMNA	Reported as heterozygous splice-site–mediated familial disease; variable expressivity with cardiomyopathy/conduction overlap	Adult-onset sick sinus syndrome, conduction disease, dilated cardiomyopathy, sudden cardiac death, atrial disease/standstill overlap	Nuclear lamina dysfunction / haploinsufficiency	Exome-sequenced family study, review, rare-variant association	LMNA c.357-2A>G showed monoallelic normal-allele expression consistent with haploinsufficiency; rare-variant analyses in large bradyarrhythmia datasets implicated LMNA for all bradyarrhythmia subtypes	(zaragoza2016exomesequencingidentifies pages 1-2, iskenderov2023familialformofa pages 6-7)
ANK2	Loss-of-function associated with incomplete penetrance and likely modifier effects	Sinus bradycardia, atrial fibrillation, broader complex arrhythmia phenotypes	Trafficking / membrane scaffolding (ankyrin-B-dependent ion channel localization)	Review, cited family/genetic evidence	No disease-specific effect size given in retrieved context; highlighted as a familial SSS contributor with environmental/genetic modifiers likely influencing expression	(iskenderov2023familialformofa pages 6-7, li2024cardiacconductiondiseases pages 3-4)
MYH6	Rare coding variation implicated in SSS susceptibility; likely variable expressivity	Sick sinus syndrome; atrial electrical/mechanical dysfunction overlap	Contractile / structural cardiomyocyte program affecting atrial/SAN biology	GWAS, review	2021 SSS GWAS highlighted a previously reported MYH6 missense signal among associated loci	(thorolfsdottir2021geneticinsightinto pages 2-3, li2024cardiacconductiondiseases pages 3-4)
RYR2	Familial contributor noted in reviews; may overlap with other inherited arrhythmia phenotypes	Sinus bradycardia / SAN dysfunction, atrial arrhythmias	Ca2+ clock / SR Ca2+ release	Review, cited experimental studies	No direct human effect estimate in retrieved context; repeatedly cited as part of calcium-handling gene set linked to familial SND/SSS	(iskenderov2023familialformofa pages 1-3, li2024cardiacconductiondiseases pages 3-4, iskenderov2023familialformofa pages 9-10)
CASQ2	Familial contributor; often discussed through calcium-handling models and arrhythmia overlap	Sinoatrial node dysfunction, bradycardia, atrial arrhythmias	Ca2+ clock / SR Ca2+ buffering	Review, animal-model-backed mechanistic evidence	Retrieved context notes CASQ2 deletion can cause SAN dysfunction in models; no human quantitative estimate given in context	(iskenderov2023familialformofa pages 1-3, li2024cardiacconductiondiseases pages 3-4, iskenderov2023familialformofa pages 9-10)
CACNA1D	Mendelian contributor in some families; channelopathy affecting pacemaker depolarization	Sinus bradycardia / SAN dysfunction	Ca2+ clock / L-type Ca2+ current supporting diastolic depolarization	Review	No quantitative penetrance estimate in retrieved context; listed among core familial SND genes in 2024 review	(iskenderov2023familialformofa pages 6-7, li2024cardiacconductiondiseases pages 3-4)
GNB2 / GNB5	GNB2 linked to familial sinus-node/AV conduction dysfunction; GNB5 often autosomal recessive multisystem syndrome with bradycardia	Sinus bradycardia, SAN dysfunction, AV conduction disease; GNB5 additionally cognitive/neurodevelopmental features	G-protein signaling / autonomic-pacemaker coupling	Review	No effect size given in retrieved context; both genes highlighted as Mendelian contributors to SAN disease	(li2024cardiacconductiondiseases pages 3-4, maarel2023geneticsofsinoatrial pages 14-15)
KRT8	Common/low-frequency risk variant rather than classic Mendelian familial gene in available evidence	SSS susceptibility; apparently more SSS-specific than broader arrhythmia spectrum in the cited GWAS	Intermediate filament / structural cell integrity	GWAS/meta-analysis	p.Gly62Cys had OR 1.44 in heterozygotes and OR 13.99 in homozygotes; described as the only reported SSS variant in that study not associating with other arrhythmias/CVD	(thorolfsdottir2021geneticinsightinto pages 2-3)
TTN	May act as susceptibility / modifier gene; also appears in families with compound variation	Sick sinus syndrome, pacemaker implantation risk, atrial fibrillation overlap, cardiomyopathy overlap	Sarcomeric / structural myocardial substrate	Family study, GWAS/rare-variant analyses, review	2025 bradyarrhythmia genetics summary in prior search implicated TTN for pacemaker implantation; 2018 family report found TTN variant alongside CACNA1C variants in SSS pedigree	(li2024cardiacconductiondiseases pages 3-4)
CACNA1C	Candidate familial susceptibility gene in compound-variant families	Sinus bradycardia / SSS, early repolarization, atrial fibrillation in reported pedigree	Ca2+ channel / membrane clock	Family study, review	2018 family carried CACNA1C p.V596M and p.A1782T with TTN p.R16472H; complex overlapping variants associated with more severe phenotype in proband	(li2024cardiacconductiondiseases pages 3-4)

Table: This table summarizes the main genes implicated in familial sick sinus syndrome/sinus node dysfunction, with inheritance patterns, phenotypes, mechanisms, and evidence types supported by the retrieved workspace context. It is useful as a compact gene-to-phenotype/mechanism map for the disease knowledge base.

Key limitations of the current evidence pull

PMIDs were not consistently available in the retrieved full-text excerpts for multiple 2023–2024 papers (e.g., DMM 2023 review; Expert Opin Ther Targets 2024 review; MDPI guideline summary), despite DOIs and URLs being available. (maarel2023geneticsofsinoatrial pages 1-2, li2024cardiacconductiondiseases pages 3-4, silvetti2024newguidelinesof pages 1-2)
MONDO, Orphanet, and MeSH identifiers were not present in the retrieved texts; direct database lookup would be needed for a complete identifier panel.
Quantitative phenotype frequencies are limited in the retrieved evidence (beyond the 2023 review’s symptom/tachy-brady estimates and GWAS effect sizes).

References

(maarel2023geneticsofsinoatrial pages 1-2): Lieve E. van der Maarel, Alex V. Postma, and Vincent M. Christoffels. Genetics of sinoatrial node function and heart rate disorders. Disease Models & Mechanisms, May 2023. URL: https://doi.org/10.1242/dmm.050101, doi:10.1242/dmm.050101. This article has 21 citations and is from a domain leading peer-reviewed journal.
(li2024cardiacconductiondiseases pages 3-4): Tingting Li, Qussay Marashly, Jitae A. Kim, Na Li, and Mihail G. Chelu. Cardiac conduction diseases: understanding the molecular mechanisms to uncover targets for future treatments. Expert Opinion on Therapeutic Targets, 28:385-400, May 2024. URL: https://doi.org/10.1080/14728222.2024.2351501, doi:10.1080/14728222.2024.2351501. This article has 5 citations and is from a peer-reviewed journal.
(thorolfsdottir2021geneticinsightinto pages 2-3): Rosa B Thorolfsdottir, Gardar Sveinbjornsson, Hildur M Aegisdottir, Stefania Benonisdottir, Lilja Stefansdottir, Erna V Ivarsdottir, Gisli H Halldorsson, Jon K Sigurdsson, Christian Torp-Pedersen, Peter E Weeke, Søren Brunak, David Westergaard, Ole B Pedersen, Erik Sorensen, Kaspar R Nielsen, Kristoffer S Burgdorf, Karina Banasik, Ben Brumpton, Wei Zhou, Asmundur Oddsson, Vinicius Tragante, Kristjan E Hjorleifsson, Olafur B Davidsson, Sridharan Rajamani, Stefan Jonsson, Bjarni Torfason, Atli S Valgardsson, Gudmundur Thorgeirsson, Michael L Frigge, Gudmar Thorleifsson, Gudmundur L Norddahl, Anna Helgadottir, Solveig Gretarsdottir, Patrick Sulem, Ingileif Jonsdottir, Cristen J Willer, Kristian Hveem, Henning Bundgaard, Henrik Ullum, David O Arnar, Unnur Thorsteinsdottir, Daniel F Gudbjartsson, Hilma Holm, Kari Stefansson, Steffen Andersen, Christian Erikstrup, Thomas F Hansen, Henrik Hjalgrim, Gregor Jemec, Poul Jennum, Mette Nyegaard, Mie T Bruun, Mikkel Petersen, Thomas Werge, and Per I Johansson. Genetic insight into sick sinus syndrome. European Heart Journal, 42:1959-1971, Feb 2021. URL: https://doi.org/10.1093/eurheartj/ehaa1108, doi:10.1093/eurheartj/ehaa1108. This article has 66 citations and is from a highest quality peer-reviewed journal.
(iskenderov2023familialformof pages 1-3): BH Iskenderov. Familial form of sick sinus syndrome. new views on polygenic origin and prospects for gene therapy. Unknown journal, 2023.
(iskenderov2023familialformofa pages 1-3): BH Iskenderov. Familial form of sick sinus syndrome. new views on polygenic origin and prospects for gene therapy. Unknown journal, 2023.
(silvetti2024newguidelinesof pages 1-2): Massimo Stefano Silvetti, Diego Colonna, Fulvio Gabbarini, Giulio Porcedda, Alessandro Rimini, Antonio D’Onofrio, and Loira Leoni. New guidelines of pediatric cardiac implantable electronic devices: what is changing in clinical practice? Journal of Cardiovascular Development and Disease, 11:99, Mar 2024. URL: https://doi.org/10.3390/jcdd11040099, doi:10.3390/jcdd11040099. This article has 16 citations.
(zaragoza2016exomesequencingidentifies pages 1-2): Michael V. Zaragoza, Lianna Fung, Ember Jensen, Frances Oh, Katherine Cung, Linda A. McCarthy, Christine K. Tran, Van Hoang, Simin A. Hakim, and Anna Grosberg. Exome sequencing identifies a novel lmna splice-site mutation and multigenic heterozygosity of potential modifiers in a family with sick sinus syndrome, dilated cardiomyopathy, and sudden cardiac death. PLOS ONE, 11:e0155421, May 2016. URL: https://doi.org/10.1371/journal.pone.0155421, doi:10.1371/journal.pone.0155421. This article has 43 citations and is from a peer-reviewed journal.
(schweizer2014thesymptomcomplex pages 1-2): Patrick A. Schweizer, Julian Schröter, Sebastian Greiner, Jan Haas, Pessah Yampolsky, Derliz Mereles, Sebastian J. Buss, Claudia Seyler, Claus Bruehl, Andreas Draguhn, Michael Koenen, Benjamin Meder, Hugo A. Katus, and Dierk Thomas. The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the hcn4 channel. Journal of the American College of Cardiology, 64 8:757-67, Aug 2014. URL: https://doi.org/10.1016/j.jacc.2014.06.1155, doi:10.1016/j.jacc.2014.06.1155. This article has 172 citations and is from a highest quality peer-reviewed journal.
(verkerk2023functionalcharacterizationof pages 1-2): Arie Verkerk and Ronald Wilders. Functional characterization of the a414g loss-of-function mutation in hcn4 associated with sinus bradycardia. Cardiogenetics, 13:117-134, Aug 2023. URL: https://doi.org/10.3390/cardiogenetics13030012, doi:10.3390/cardiogenetics13030012. This article has 1 citations.
(maarel2023geneticsofsinoatrial pages 2-3): Lieve E. van der Maarel, Alex V. Postma, and Vincent M. Christoffels. Genetics of sinoatrial node function and heart rate disorders. Disease Models & Mechanisms, May 2023. URL: https://doi.org/10.1242/dmm.050101, doi:10.1242/dmm.050101. This article has 21 citations and is from a domain leading peer-reviewed journal.
(silvetti2024newguidelinesof pages 2-4): Massimo Stefano Silvetti, Diego Colonna, Fulvio Gabbarini, Giulio Porcedda, Alessandro Rimini, Antonio D’Onofrio, and Loira Leoni. New guidelines of pediatric cardiac implantable electronic devices: what is changing in clinical practice? Journal of Cardiovascular Development and Disease, 11:99, Mar 2024. URL: https://doi.org/10.3390/jcdd11040099, doi:10.3390/jcdd11040099. This article has 16 citations.
(maarel2023geneticsofsinoatrial pages 14-15): Lieve E. van der Maarel, Alex V. Postma, and Vincent M. Christoffels. Genetics of sinoatrial node function and heart rate disorders. Disease Models & Mechanisms, May 2023. URL: https://doi.org/10.1242/dmm.050101, doi:10.1242/dmm.050101. This article has 21 citations and is from a domain leading peer-reviewed journal.
(iskenderov2023familialformofa pages 6-7): BH Iskenderov. Familial form of sick sinus syndrome. new views on polygenic origin and prospects for gene therapy. Unknown journal, 2023.
(NCT03361189 chunk 2): Jeremy P. Moore, MD. Specialized Pacing for Patients With Congenital Heart Disease. University of California, Los Angeles. 2021. ClinicalTrials.gov Identifier: NCT03361189
(silvetti2024newguidelinesof pages 4-5): Massimo Stefano Silvetti, Diego Colonna, Fulvio Gabbarini, Giulio Porcedda, Alessandro Rimini, Antonio D’Onofrio, and Loira Leoni. New guidelines of pediatric cardiac implantable electronic devices: what is changing in clinical practice? Journal of Cardiovascular Development and Disease, 11:99, Mar 2024. URL: https://doi.org/10.3390/jcdd11040099, doi:10.3390/jcdd11040099. This article has 16 citations.
(iskenderov2023familialformof pages 9-10): BH Iskenderov. Familial form of sick sinus syndrome. new views on polygenic origin and prospects for gene therapy. Unknown journal, 2023.
(NCT00314223 chunk 1): Identification of Gene Polymorphism in Patients With Sick Sinus Syndrome in Chinese Population in Taiwan. China Medical University Hospital. 2006. ClinicalTrials.gov Identifier: NCT00314223
(NCT01310907 chunk 1): Identify the Genes Polymorphisms Related to Non-familial Bradyarrhythmia. China Medical University Hospital. 2011. ClinicalTrials.gov Identifier: NCT01310907
(NCT01310920 chunk 1): The Role of Angiotensinogen Gene Polymorphism in the Pathogenesis of Non-familial Sick Sinus Syndrome. China Medical University Hospital. 2011. ClinicalTrials.gov Identifier: NCT01310920
(NCT00664807 chunk 1): Medtronic Genetic Arrhythmia Markers for Early Detection (GAME Study). Medtronic Corporate Technologies and New Ventures. 2008. ClinicalTrials.gov Identifier: NCT00664807
(sanner2021anovelscn5a pages 9-9): Karolina Sanner, Johanna Mueller-Leisse, Christos Zormpas, David Duncker, Andreas Leffler, and Christian Veltmann. A novel scn5a variant causes temperature-sensitive loss of function in a family with symptomatic brugada syndrome, cardiac conduction disease, and sick sinus syndrome. Cardiology, 146:754-762, Jul 2021. URL: https://doi.org/10.1159/000518210, doi:10.1159/000518210. This article has 7 citations and is from a peer-reviewed journal.
(iskenderov2023familialformofa pages 9-10): BH Iskenderov. Familial form of sick sinus syndrome. new views on polygenic origin and prospects for gene therapy. Unknown journal, 2023.

Ask OpenScientist

OpenScientist Report

Inheritance

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Treatments

Environmental Factors

Source YAML

References & Deep Research

Deep Research

Familial Sick Sinus Syndrome (Familial Sinus Node Dysfunction): Disease Characteristics Research Report

Target Disease

Executive overview

1. Disease Information

1.1 What is the disease?

1.2 Key identifiers (available from retrieved evidence)

1.3 Common synonyms / alternative names

1.4 Evidence sources

2. Etiology

2.1 Disease causal factors

2.2 Risk factors

Genetic risk factors

Non-genetic / clinical risk factors

Causal inference from human genetics

2.3 Protective factors

2.4 Gene–environment interactions

3. Phenotypes

3.1 Core phenotype set (with suggested HPO terms)

3.2 Temporal features (onset and progression)

3.3 Quality of life impact

4. Genetic / Molecular Information

4.1 Causal genes (high-confidence in retrieved evidence)

4.2 Pathogenic variants and functional consequences (examples)

4.3 Modifier genes / oligogenicity

4.4 Epigenetic information

4.5 Chromosomal abnormalities

5. Environmental Information

6. Mechanism / Pathophysiology

6.1 Conceptual model (upstream → downstream causal chain)

6.2 Molecular pathways and processes (with ontology suggestions)

6.3 Cell types (CL term suggestions)

6.4 Tissue and anatomy (UBERON suggestions)

6.5 Advanced molecular profiling

7. Anatomical Structures Affected

8. Temporal Development

9. Inheritance and Population

9.1 Inheritance patterns

9.2 Epidemiology and statistics

9.3 Penetrance/expressivity and modifiers

10. Diagnostics

10.1 Clinical tests

10.2 Genetic testing strategy (real-world approach)

10.3 Differential diagnosis

11. Outcomes / Prognosis

12. Treatment

12.1 Standard of care: cardiac pacing

12.2 Pediatric pacing guideline evidence (2024)

12.3 Emerging approaches / expert opinion

12.4 MAXO suggestions

13. Prevention

14. Other Species / Natural Disease

15. Model Organisms and Experimental Models

Recent developments (prioritizing 2023–2024)

Applications and real-world implementation

Expert opinions and authoritative analyses

Relevant statistics and data (recent/large studies)

Clinical trials / registries (ClinicalTrials.gov)

Gene-centric summary table

Key limitations of the current evidence pull